{"disease":{"id":"patients-recieving-anti-pd-1-or-anti-pd-l1-immunotherapies","name":"patients recieving anti pd 1 or anti pd l1 immunotherapies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04609930","title":"Impact of Immune Checkpoint Inhibitor Therapy on Type 2 Inflammation","phase":"","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"University Hospital, Montpellier","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}